Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Lantern Pharma Inc. (LTRN) had Earnings per Share (EPS) (Basic) of $-1.57 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-17.12M |
|
-- |
|
-- |
|
$17.98M |
|
$-17.98M |
|
$0.86M |
|
$-17.12M |
|
$-17.12M |
|
$-17.12M |
|
$-17.12M |
|
$-17.12M |
|
$-17.12M |
|
$-17.98M |
|
$-18.16M |
|
10.90M |
|
10.90M |
|
|
Earnings per Share (EPS) (Basic) |
$-1.57 |
$-1.57 |
|
| Balance Sheet Financials | |
$10.80M |
|
$0.03M |
|
$0.23M |
|
$11.04M |
|
$4.50M |
|
-- |
|
-- |
|
$4.50M |
|
$6.53M |
|
$6.53M |
|
$6.53M |
|
11.26M |
|
| Cash Flow Statement Financials | |
$-15.68M |
|
$11.06M |
|
$1.50M |
|
$7.51M |
|
$4.42M |
|
$-3.09M |
|
$0.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.68M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-262.00% |
|
-262.00% |
|
-155.13% |
|
-262.00% |
|
$0.58 |
|
$-1.44 |
|
$-1.44 |
|